Skip to main content
. Author manuscript; available in PMC: 2020 Apr 19.
Published in final edited form as: ACS Infect Dis. 2019 Sep 18;5(11):1952–1962. doi: 10.1021/acsinfecdis.9b00284

Table 3:

Drug sensitivity against recombinant EV-D68 US/MO/14–18947 viruses

R856932 Pleconaril
CPE EC50 (μM) PRA EC50 (μM) CPE EC50 (μM) PRA EC50 (μM)
rMO WT 0.86 ± 0.14 0.39 ± 0.03 0.07 ± 0.02 0.03 ± 0.01
rMO VP1-A129V 16.6 ± 1.2 16.0 ± 7.4 0.44 ± 0.04 0.23 ± 0.04
rMO VP2-T139A 1.46 ± 0.39 1.15 ± 0.14 0.13 ± 0.05 0.13 ± 0.02

CPE: cytopathic effect assay; PRA: Plaque reduction assay; EC50 (μM) = mean ± standard deviation. The values are the mean ± standard deviation from three replicates.